Vigonvita Life Sciences Co., Ltd. (stock code: 02630) has issued a monthly update for the period ended 28 February 2026. According to the announcement dated 5 March 2026, the total authorized share capital remains at RMB 167.60 million. This is composed of 66.68 million H shares and 100.92 million unlisted shares, both at a par value of RMB 1 per share.

No new shares were issued or cancelled during the month, leaving the number of issued H shares at approximately 66.68 million and unlisted shares at around 100.92 million. The company confirmed that its public float requirement stands at 25% of the total H share class, and that this requirement is being met. No share options, warrants, or convertible instruments were disclosed.

The update also confirms compliance with applicable listing rules and regulations for the reported period, with no changes made to the shareholdings or treasury shares. The appointment of relevant officers and the board’s approvals have been duly completed in accordance with all relevant legal requirements.